At the height of the pandemic in February of 2021, Prime Minister Justin Trudeau announced he had found a partner to make millions of doses of COVID-19 vaccines in a new factory his government was building to assuage concerns that Canada didn\u2019t have enough manufacturing capacity to make its own shots.<\/p>\n
More than three years later, that partner, Novavax Inc., won\u2019t be making vaccines at the publicly owned plant in Montreal for the 2024-2025 season, which is part of the reason the federal government isn\u2019t ordering any of the company\u2019s shots for Canadians.<\/p>\n
Novavax\u2019s decision has left managers of the Biologics Manufacturing Centre (BMC), which was built with nearly $130-million in federal funds, working to drum up other business for a 55,000-square-foot plant that was completed in the summer of 2021. No other vaccines or biologic medications are currently being made there, according to the president of the non-profit corporation that oversees the BMC.<\/p>\n","protected":false},"excerpt":{"rendered":"
At the height of the pandemic in February of 2021, Prime Minister Justin Trudeau announced he had found a partner to make millions of doses…<\/p>\n